Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06418542
PHASE4

Contrast Nephropathy Associated FFA

Sponsor: Saglik Bilimleri Universitesi

View on ClinicalTrials.gov

Summary

After the use of iodinated contrast agents, there is a risk of developing contrast nephropathy. Limited data in the literature are available on the incidence of contrast nephropathy after fluorescein angiography (FFA), which is an iodine-free organic contrast. Additionally, factors associated with contrast nephropathy after FFA are not clearly understood. Our study aims to evaluate these points.

Official title: Assessment of the Frequency of Fundus Fluorescein Angiography Relationship With Contrast Nephropathy and Associated Factors

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2024-02-01

Completion Date

2024-12-01

Last Updated

2024-05-17

Healthy Volunteers

No

Interventions

DEVICE

use of florescein

Fluorescein, an organic contrast agent, is used in FFA to detect retinal pathologies.

Locations (1)

Saglik Bilimleri University

Istanbul, Turkey (Türkiye)